Related Experiment Video

Updated: Jan 21, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

22.3K

Treatment patterns and deep molecular response in chronic phase - chronic myeloid leukemia patients treated with

Jorge Cortes1, Lynn Huynh2, Estella Mendelson3

  • 1The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Leukemia & Lymphoma
|August 15, 2019
PubMed

Insights

Second-line nilotinib demonstrated superior efficacy in helping chronic myeloid leukemia (CML) patients achieve deep molecular response (MR4.5) compared to dasatinib. This finding is crucial for optimizing tyrosine kinase inhibitor (TKI) treatment strategies.

Area of Science:

  • Hematology
  • Oncology
  • Pharmacology

Background:

  • Achieving MR4.5 (BCR-ABL1 ≤ 0.0032% IS) is a key goal in chronic myeloid leukemia (CML) treatment.
  • Tyrosine kinase inhibitors (TKIs) are standard therapy for CML, with second-line options including nilotinib and dasatinib.

Purpose of the Study:

  • To compare treatment patterns and time to achieve MR4.5 in CML patients receiving second-line nilotinib versus dasatinib across 10 countries.
  • To evaluate the relative efficacy of nilotinib and dasatinib in achieving deep molecular response in CML.

Main Methods:

  • A multivariate Cox proportional hazards model was employed to analyze time to MR4.5.
  • The model incorporated competing risks (TKI resistance), country clustering (random effects), and baseline covariate adjustments.
  • Data from 280 patients (135 nilotinib, 145 dasatinib) with median treatment durations of 19.1 and 18.7 months, respectively, were analyzed.

Main Results:

  • Nilotinib showed a statistically significant advantage over dasatinib in achieving MR4.5 (adjusted hazard ratio = 1.37, 95% CI [1.11, 1.69]).
  • Treatment patterns varied by region, but the efficacy of nilotinib in achieving MR4.5 was consistent.

Conclusions:

  • Second-line nilotinib appears to be more effective than dasatinib in achieving MR4.5 in CML patients.
  • These findings support nilotinib as a potentially preferred second-line TKI for optimizing deep molecular response in CML management.
Keywords:
Chronic myeloid leukemiadeep molecular responsenilotinibtargeted therapiestyrosine kinase inhibitor

More Related Videos

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.6K
Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.5K

Related Concept Videos

Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
11.2K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
680
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.1K
Run Charts01:12

Run Charts

Run charts serve as an essential instrument for visualizing the performance of various processes over time, enabling the identification of trends and patterns crucial for quality improvement. These charts map out a series of data points chronologically, offering insights into the stability and efficiency of a process. A run chart's creation involves plotting data points on a graph, with the time intervals on the horizontal axis and the specific measurements on the vertical axis. For...
276
The R Chart01:02

The R Chart

In statistical process control, control charts, particularly R charts, are instrumental in monitoring process variations and identifying non-random patterns that run charts might miss. R charts track the variability within process subgroups, which is crucial when standard deviation use is impractical or unknown process variations exist.
R charts are pivotal for pinpointing shifts in process variability. Stability is indicated when all data points remain within the defined upper and lower...
379
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
326